WO1993006856A1 - Treating ophthalmic fibrosis using interferon-alpha - Google Patents
Treating ophthalmic fibrosis using interferon-alpha Download PDFInfo
- Publication number
- WO1993006856A1 WO1993006856A1 PCT/AU1992/000541 AU9200541W WO9306856A1 WO 1993006856 A1 WO1993006856 A1 WO 1993006856A1 AU 9200541 W AU9200541 W AU 9200541W WO 9306856 A1 WO9306856 A1 WO 9306856A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- interferon
- patient
- treatment
- surgery
- diluent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92921557A EP0607275A4 (en) | 1991-10-11 | 1992-10-12 | Treating ophthalmic fibrosis using interferon-alpha. |
AU27748/92A AU669132B2 (en) | 1991-10-11 | 1992-10-12 | Treating ophthalmic fibrosis using interferon-alpha |
JP5506481A JPH07501320A (en) | 1991-10-11 | 1992-10-12 | Treatment of ocular fibrosis with interferon alpha |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPK886591 | 1991-10-11 | ||
AUPK8865 | 1991-10-11 | ||
AUPK9080 | 1991-10-22 | ||
AUPK908091 | 1991-10-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993006856A1 true WO1993006856A1 (en) | 1993-04-15 |
Family
ID=25644122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1992/000541 WO1993006856A1 (en) | 1991-10-11 | 1992-10-12 | Treating ophthalmic fibrosis using interferon-alpha |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0607275A4 (en) |
JP (1) | JPH07501320A (en) |
CA (1) | CA2120950A1 (en) |
WO (1) | WO1993006856A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996029092A1 (en) * | 1995-03-17 | 1996-09-26 | Toray Industries, Inc. | Corneal vascularization inhibitor |
EP0797998A1 (en) * | 1995-11-17 | 1997-10-01 | Toray Industries, Inc. | Endothelial cell protective |
WO1998029069A2 (en) * | 1997-01-02 | 1998-07-09 | Allergan Sales, Inc. | Method for changing the refractive power of an eye |
WO2006136116A1 (en) * | 2005-06-24 | 2006-12-28 | Centro De Ingenieria Genetica Y Biotecnologia | Use of interferon-alpha in order to obtain a compound for the treatment of optical neuromyelitis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2243161A1 (en) * | 1996-11-22 | 1998-05-28 | Toray Industries, Inc. | Use of interferon-beta to treat retinal edema |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0082481A1 (en) * | 1981-12-23 | 1983-06-29 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
AU6829287A (en) * | 1986-02-05 | 1987-08-06 | Dr. Karl Thomae Gmbh | Stabilised formulations of alpha-interferon |
AU7730787A (en) * | 1986-08-21 | 1988-02-25 | Dr. Karl Thomae Gmbh | Formulations of alpha-interferons |
WO1988003411A1 (en) * | 1986-11-06 | 1988-05-19 | Amarillo Cell Culture Company, Inc. | Improved interferon therapy |
AU6820190A (en) * | 1988-01-25 | 1991-03-14 | Baker Norton Pharmaceuticals, Inc. | Method of treating fibrotic disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6391331A (en) * | 1986-10-03 | 1988-04-22 | Senjiyu Seiyaku Kk | Ophthalmic aqueous composition |
-
1992
- 1992-10-12 JP JP5506481A patent/JPH07501320A/en active Pending
- 1992-10-12 CA CA002120950A patent/CA2120950A1/en not_active Abandoned
- 1992-10-12 EP EP92921557A patent/EP0607275A4/en not_active Withdrawn
- 1992-10-12 WO PCT/AU1992/000541 patent/WO1993006856A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0082481A1 (en) * | 1981-12-23 | 1983-06-29 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
AU6829287A (en) * | 1986-02-05 | 1987-08-06 | Dr. Karl Thomae Gmbh | Stabilised formulations of alpha-interferon |
AU7730787A (en) * | 1986-08-21 | 1988-02-25 | Dr. Karl Thomae Gmbh | Formulations of alpha-interferons |
WO1988003411A1 (en) * | 1986-11-06 | 1988-05-19 | Amarillo Cell Culture Company, Inc. | Improved interferon therapy |
AU6820190A (en) * | 1988-01-25 | 1991-03-14 | Baker Norton Pharmaceuticals, Inc. | Method of treating fibrotic disorders |
Non-Patent Citations (1)
Title |
---|
See also references of EP0607275A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996029092A1 (en) * | 1995-03-17 | 1996-09-26 | Toray Industries, Inc. | Corneal vascularization inhibitor |
EP0797998A1 (en) * | 1995-11-17 | 1997-10-01 | Toray Industries, Inc. | Endothelial cell protective |
EP0797998A4 (en) * | 1995-11-17 | 2003-01-15 | Toray Industries | Endothelial cell protective |
WO1998029069A2 (en) * | 1997-01-02 | 1998-07-09 | Allergan Sales, Inc. | Method for changing the refractive power of an eye |
WO1998029069A3 (en) * | 1997-01-02 | 1998-10-08 | Allergan Inc | Method for changing the refractive power of an eye |
WO2006136116A1 (en) * | 2005-06-24 | 2006-12-28 | Centro De Ingenieria Genetica Y Biotecnologia | Use of interferon-alpha in order to obtain a compound for the treatment of optical neuromyelitis |
Also Published As
Publication number | Publication date |
---|---|
JPH07501320A (en) | 1995-02-09 |
CA2120950A1 (en) | 1993-04-15 |
EP0607275A1 (en) | 1994-07-27 |
EP0607275A4 (en) | 1995-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5811446A (en) | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor | |
Freeman et al. | Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis | |
Fujitani et al. | Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy | |
EP0179477B1 (en) | Fibronectin preparations | |
JPH10158188A (en) | Composition for treating cornea | |
CA2138644A1 (en) | Method of treating ophthalmic disorders using tgf-.beta. | |
Phinney et al. | Corneal edema related to accidental Hibiclens exposure | |
US7977385B2 (en) | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye | |
Pfister | Clinical measures to promote corneal epithelial healing | |
AU2009201897B2 (en) | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye | |
Gelender | Bacterial endophthalmitis following cutting of sutures after cataract surgery | |
WO1993006856A1 (en) | Treating ophthalmic fibrosis using interferon-alpha | |
US5863530A (en) | Treating ophthalmic fibrosis using interferon-α | |
WO2018066963A1 (en) | Pharmaceutical composition for treating corneal injury containing 8-oxo-deoxyguanosine or pharmaceutically acceptable salt thereof as active ingredient | |
AU2774892A (en) | Treating ophthalmic fibrosis using interferon-alpha | |
Ohashi | Treatment of herpetic keratitis with acyclovir: benefits and problems | |
JPH06271478A (en) | Agent for treating dry eye | |
JPH08503968A (en) | Composition containing growth factor and antimetabolite | |
US20140112902A1 (en) | Methods for treatment of inflammatory and infectious diseases | |
EP0080032A2 (en) | Pharmaceutical preparation for treating herpetic lesions | |
US5948403A (en) | Corneal angiogenesis inhibitor | |
Genvert et al. | Treatment of marginal corneal ulcers with cryotherapy and conjunctival recession or resection | |
JP3118584B2 (en) | Postoperative astigmatism prevention agent | |
EP0885612A1 (en) | Pirenoxine for the topical treatment of inflammatory conditions | |
JPH0881389A (en) | Agent for multiplying pigment epithelial cell of retina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2120950 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992921557 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992921557 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1994 211655 Country of ref document: US Date of ref document: 19940801 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992921557 Country of ref document: EP |